Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
Collagen IV: a critical new starting point for engineering upper airways
Martina M. De Santis, Darcy E. Wagner
Eur Respir J, 55 (6) 2001130; 10.1183/13993003.01130-2020
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Martina M. De Santis, Darcy E. Wagner. Collagen IV: a critical new starting point for engineering upper airways. Eur Respir J, 55 (6) 2001130; 10.1183/13993003.01130-2020
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Collagen type III content in large airways and distal lung of fatal asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 279s
Collagen I, III and IV content in airways and lung parenchyma of COPD patients
Source: Annual Congress 2010 - Proteases and the matrix
Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development?
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Lung tissue engineering: making a functional human lung
Source: International Congress 2016 – Regeneratives approaches to COPD
More than mechanics: what determines the upper airway diameter?
Source: Sleep and Breathing Conference 2021
The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction
Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights
Prolyl-3-hydroxylase 4 (P3H4), a novel player in collagen synthesis and secretion in lung fibroblasts
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
A new piece in the puzzle: the eosinophil and the development of COPD
Source: Eur Respir J, 58 (4) 2101105; 10.1183/13993003.01105-2021
Type V collagen nasal tolerance regulates collagen mRNA synthesis in pulmonary remodeling of experimental systemic sclerosis
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Bioengineered airway epithelial grafts with mucociliary function based on collagen IV- and laminin-containing extracellular matrix scaffolds
Source: Eur Respir J, 55 (6) 1901200; 10.1183/13993003.01200-2019
Upper and lower airways: the same tissue?
Source: Eur Respir Monogr 2017; 76: 1-11
Modifying remodelling and repair in ILD: a new therapeutic approach?
Source: Annual Congress 2006 - PG15 - Remodelling and repair in lung disease
Identifying a therapeutic target for ablating new blood vessel formation in patients with asthma
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
The role of biomarkers in management of interstitial lung disease: implications of biomarkers derived from type II pneumocytes
Source: Eur Respir Mon; 2009: 46: 47–66
Disruption of the lung structure maintenance programme: a comprehensive view of emphysema development
Source: Eur Respir J 2011; 37: 752-754
YI03 - Lung tissue engineering: generation and characterization of decellularized lung scaffolds for stem cell differentiation
Source: Lung Science Conference 2012 - Rebuilding a diseased lung: Repair and regeneration
Hyaluronic acid increases the airway epithelial integrity
Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD
Late stage of experimental pulmonary fibrosis is modulated by collagen V
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Recombinant human pentraxin-2 for idiopathic pulmonary fibrosis: Design of STARSCAPE-OLE, a Phase III open label extension study
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Lung function in the elderly: time for new reference values?
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology